Cargando…
Rhythm Control Better Prevents Dementia than Rate Control Strategies in Patients with Atrial Fibrillation—A Nationwide Cohort Study
Background: Atrial fibrillation (AF) increases the risk of dementia. Whether the pharmacological rhythm control of AF can reduce the risk of dementia compared to the rate control strategy remains unclear. We hypothesize that the rhythm control strategy is better than the rate control strategy in pre...
Autores principales: | Lin, Jiunn-Cherng, Li, Cheng-Hung, Chen, Yun-Yu, Weng, Chi-Jen, Chien, Yu-Shan, Wu, Shang-Ju, Lo, Chu-Pin, Tien, Hui-Chun, Lin, Ching-Heng, Huang, Jin-Long, Lin, Yenn-Jiang, Hsieh, Yu-Cheng, Chen, Shih-Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025212/ https://www.ncbi.nlm.nih.gov/pubmed/35455688 http://dx.doi.org/10.3390/jpm12040572 |
Ejemplares similares
-
Data for rate versus rhythm control strategy on stroke and mortality in patients with atrial fibrillation
por: Weng, Chi-Jen, et al.
Publicado: (2018) -
Atrial fibrillation as a contributor to the mortality in patients with dementia: A nationwide cohort study
por: Chen, Yun-Yu, et al.
Publicado: (2023) -
Efficacy of Cryoballoon Ablation for Atrial Fibrillation and Recurrence Predictors in an Asian Cohort
por: Wu, Shang-Ju, et al.
Publicado: (2022) -
Ablation of atrial fibrillation and dementia risk reduction during long-term follow-up: a nationwide population-based study
por: Li, Guan-Yi, et al.
Publicado: (2023) -
Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study
por: Chan, Cheng-Wei, et al.
Publicado: (2018)